Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
Trader Note — 15007 total
Applied Digital Corporation enters the mid-August session with every positioning signal pointing in the same direction — and none of them are comfortable for bulls. The sharpest development this week is in options. The…
Public Storage enters the back half of August with a mildly defensive tilt — options traders slightly more cautious than usual, short sellers rebuilding positions after a steep unwind, and a Street still nudging…
Prudential Financial heads into late August with analysts steadily lifting price targets — yet keeping their ratings firmly in neutral or negative territory, leaving the stock in an awkward no-man's land just above…
Progressive Corporation has just reported August earnings, and the options market is flashing its most defensive reading of the past year — even as short sellers remain firmly on the sidelines. The standout signal this…
PVH heads into its August 27 earnings report with short sellers reducing exposure and options defensiveness easing — a notable shift for a stock that fell nearly 20% after its last print. Short interest has quietly…
ConocoPhillips continues its post-earnings climb, but the options market has turned notably more defensive even as the analyst upgrade cycle rolls on — the sharpest divergence in the stock's positioning for months. The…
PFE has extended its recovery to close at $27.25, up 8.8% over the past month, and the insider buying story that defined last week's note has grown more compelling — the CEO himself stepped in on August 12. Albert…
OSI Systems arrives at its August 20 earnings print down 6% on the week and carrying the weight of a historically ugly prior-quarter reaction — but the short-selling community has spent the past month quietly reducing…
NVIDIA reported Q2 fiscal 2027 results on August 19, and the stock's first reaction is a 2.3% pullback to $219.74 — a modest decline that follows a pattern bears have been unable to exploit all summer. The…
Nucor Corporation enters the final stretch of August with its options defensiveness intact — and the broader steel sector now joining the retreat. The put/call ratio remains the sharpest signal on the tape. It spiked…
Novavax heads into the back half of August with one of the most persistent short positions in US biotech — and a borrow market that just shifted gears in a way worth watching. Short interest is the defining feature of…
Northrop Grumman is one of the week's stronger performers among large-cap defense names, up 3.3% Tuesday and 2.3% on the week to close at $589.14 — a move that has left at least one analyst target already looking stale…
Netflix is now four weeks into a clean recovery from its post-earnings low, but the Street's target resets and a cluster of insider sales mean the path back to prior highs faces real friction. The short-side picture…
Morgan Stanley heads into the final stretch of August with the short story essentially closed — the live question is whether the stock at $217.55 can close a meaningful gap to analyst targets that mostly cluster…
Micron Technology delivered a sharp reversal Tuesday, dropping 7% to $940.76, even as the weekly tape still shows an 8.3% gain — the tension between a strong recovery and a sudden single-day sell-off is the story…
Strategy Inc is now six weeks into a sustained short unwind — but the stock keeps falling anyway, which is the tension worth watching this week. Short interest has dropped another 19% over the past week, bringing the…
Microsoft enters the back half of August with a familiar tension: the options market has thrown up another defensive spike while short sellers continue to quietly exit — the same divergence that defined the stock two…
MET heads into the back half of August with analysts chasing the stock higher and options traders growing notably more defensive — a tension worth unpacking. The analyst upgrade cycle on MetLife has been relentless.…
MRCY enters the post-earnings session in a telling contradiction: the stock fell 7.4% on August 18 after its results, yet every analyst who updated their view that morning raised their price target. The analyst…
Merck & Co. has pulled back fractionally from its recent 12-month high, and the week's tension is straightforward: analysts keep lifting targets while insiders keep cashing out into every uptick. The stock closed at…
